External Ventricular Drain Market Size, Share & Industry Analysis, By Patient Type (Adult and Pediatric), By Application (Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Brain Tumors, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global external ventricular drain market size was valued at USD 317.6 million in 2025. The market is projected to grow from USD 337.8 million in 2026 to USD 581.2 million by 2034, exhibiting a CAGR of 7.0% during the forecast period.

An External Ventricular Drain (EVD) is a temporary neurosurgical drainage system used to remove cerebrospinal fluid (CSF) from brain ventricles and monitor intracranial pressure in critical conditions such as hydrocephalus, traumatic brain injury, subarachnoid hemorrhage, intraventricular hemorrhage, and brain tumors. The market growth is attributed to rising emergency neurosurgical procedures, increasing stroke and trauma burden, and higher demand for real-time intracranial pressure management in neuro-ICUs. In addition, EVDs remain a standard lifesaving intervention in acute brain injury care. Recent innovations are focused on reducing catheter blockage, infection, and drainage management errors.

• For instance, in 2025, Anuncia Medical received FDA Breakthrough Device Designation for ReFlow EVD, designed to restore and maintain CSF flow through a noninvasive flushing mechanism.

Leading companies in the market include Integra LifeSciences Corporation, Medtronic plc, Natus Medical Incorporated, Sophysa, and Spiegelberg GmbH & Co. KG. They emphasize creating different advanced technologies to provide better products with enhanced precision and efficacy.

EXTERNAL VENTRICULAR DRAIN MARKET TRENDS

Shift Toward Active Fluid Management Technologies is a Key Market Trend

The market is witnessing a shift from traditional passive drainage systems toward active and integrated CSF management technologies. Traditional EVDs mainly drain CSF and require manual monitoring, while newer systems aim to combine controlled drainage, irrigation, pressure monitoring, and data connectivity. The market is witnessing a rising preference for automation, closed systems, and connected neurocritical care technologies.

• For instance, in December 2022, IRRAS received U.S. FDA 510(k) clearance for its next-generation IRRAflow control unit, enabling enhanced workflow and communication with bedside monitors.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Burden of Acute Neurological Conditions to Accelerate Market Growth

The growing incidence of traumatic brain injury, intracranial hemorrhage, hydrocephalus, and stroke is driving demand for external ventricular drains. EVDs are widely used in emergency neurosurgery to relieve elevated intracranial pressure and drain excess CSF. In addition, the device is particularly important in neurocritical care, where rapid pressure control can reduce secondary brain injury. Also, increasing hospital admissions for road accidents, aneurysmal bleeding, and hemorrhagic stroke are expanding procedure volumes, implicitly impacting the global external ventricular drain market growth.

MARKET RESTRAINTS

Infection and Catheter-Related Complications to Deter Market Growth

Infection risk remains a major restraint for the market. Since EVDs create a direct pathway into the ventricular system, patients are exposed to complications such as ventriculitis, catheter blockage, hemorrhage, malposition, and accidental dislodgement. In addition, these complications can increase ICU stay, antibiotic use, repeat procedures, and overall treatment cost. Conventional EVDs also require careful handling, frequent monitoring, and strict infection-control protocols. The invasive nature of the procedure makes hospitals cautious, especially in settings with limited neurosurgical expertise. These safety concerns continue to limit broader adoption in lower-resource healthcare facilities.

MARKET OPPORTUNITIES

Development of Anti-Occlusion and Smart Drainage Systems to Offer Lucrative Market Growth Opportunities

Significant growth opportunities exist in the development of next-generation external ventricular drain systems that address the major limitations associated with conventional EVDs, including catheter occlusion, infection risk, inaccurate drainage control, and high clinical monitoring requirements. Manufacturers are increasingly focusing on innovations such as active fluid exchange systems, antimicrobial catheters, integrated intracranial pressure monitoring, automated drainage regulation, and digital connectivity with hospital monitoring platforms. These technologies have the potential to improve patient outcomes while reducing ICU workload and catheter-related complications.

MARKET CHALLENGES

Need for Skilled Neurosurgical Handling to Pose a Critical Challenge to Market Growth

The market faces challenges due to the need for highly skilled neurosurgical placement and continuous ICU-level management. Incorrect catheter positioning, drainage-level errors, blockage, and infection can directly affect patient outcomes. Moreover, EVD placement is often performed in emergency conditions, where procedure accuracy and rapid decision-making are critical. Hospitals also require trained nurses and neurocritical care teams to manage drainage height, ICP monitoring, CSF sampling, and infection prevention. In addition, these operational requirements restrict adoption in smaller hospitals and emerging markets. As a result, training, protocol standardization, and post-placement monitoring remain key challenges for wider market penetration.

Segmentation Analysis

By Patient Type

Increased Prevalence of Neurological Conditions and Strokes in Adults Boosted Segment Growth

Based on the patient type, the market is divided into adult and pediatric.

The adult segment accounted for the largest external ventricular drain market share in 2025. The segment growth is attributed to the higher incidence of stroke, traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage, and adult-onset hydrocephalus. In addition, adults are more frequently exposed to road accidents, aneurysmal rupture, hypertension-related brain bleeding, and age-related neurological complications, creating a strong demand for emergency CSF drainage.

• For instance, according to data published by NCBI in August 2022, an estimated 18.2% of the U.S. population suffers from traumatic brain injury.

The pediatric segment is anticipated to rise with a CAGR of 6.7% over the forecast period.  

To know how our report can help streamline your business, Speak to Analyst

By Application

Higher Adoption of EVD for Subarachnoid Hemorrhage Due to Substantial Benefits Fueled Segment Growth

Based on application, the market is segmented into traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage, brain tumors, and others.

In 2025, the subarachnoid hemorrhage segment dominated and held 34.1% market share. Subarachnoid hemorrhage accounts for a significant share of EVD usage as the condition often leads to acute hydrocephalus, elevated intracranial pressure, and impaired CSF circulation. Moreover, EVD placement is frequently required to drain CSF, monitor pressure, and stabilize patients during the acute phase of aneurysmal bleeding. These patients are generally treated in specialized stroke and neurocritical care units, where EVDs are part of standard emergency management.

The intracerebral hemorrhage segment is expected to register a CAGR of 7.4% during the forecast period.

By End-User

Hospitals Led Market Due to Availability of Superior Infrastructure

Based on end-user, the market is segmented into hospitals, specialty clinics, and others.

In 2025, hospitals held the highest market share, as EVD placement requires neurosurgeons, operating rooms or emergency procedure areas, imaging support, intensive care monitoring, and infection-control infrastructure. Most cases involving traumatic brain injury, hydrocephalus, subarachnoid hemorrhage, and intraventricular hemorrhage are managed in tertiary hospitals and trauma centers. Furthermore, the segment is set to hold 92.3% share in 2026.

The specialty clinics segment is projected to grow at a CAGR of 9.0% during the forecast period.

External Ventricular Drain Market Regional Outlook

By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024, valued at USD 107.5 million, and also maintained the leading share in 2025, with USD 113.9 million. The market in North America is expected to increase due to the high incidence of traumatic brain injuries, intracranial hemorrhage, hydrocephalus, and aneurysmal subarachnoid hemorrhage requiring emergency neurosurgical intervention.

U.S. External Ventricular Drain Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 94.3 million in 2026, accounting for roughly 27.9% of global sales.

Europe

Europe is projected to record a growth rate of 6.5% in the coming years, which is the second highest among all regions, and reach a valuation of USD 101.0 million in 2026. The region is estimated to witness considerable market growth due to increasing focus on improving neurocritical care outcomes and rising adoption of evidence-based intracranial pressure management protocols.

U.K. External Ventricular Drain Market

The U.K. market in 2026 is estimated at around USD 14.9 million, representing roughly 4.4% of global revenues.

Germany External Ventricular Drain Market

Germany’s market is projected to reach approximately USD 18.5 million in 2026, equivalent to around 5.5% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 76.6 million in 2026 and secure the position of the third-largest region in the market.

Japan External Ventricular Drain Market

The Japanese market in 2026 is estimated at around USD 13.5 million, accounting for roughly 4.0% of global revenues.

China External Ventricular Drain Market

China’s market is projected to reach USD 25.7 million in 2026, representing roughly 7.6% of global sales.

India External Ventricular Drain Market

The Indian market in 2026 is estimated at around USD 17.2 million, accounting for roughly 5.1% of global revenues.

Latin America and Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth during the forecast period. The Latin America market is set to reach a valuation of USD 21.4 million in 2026. Market growth in Latin America is driven by increasing healthcare investments, improving access to neurosurgical procedures, and the rising incidence of traumatic brain injuries and cerebrovascular diseases.

 In the Middle East & Africa, the GCC is set to reach a value of USD 17.9 million in 2026. Market growth in the Middle East & Africa is attributed to the growing demand for advanced critical care services.

South Africa External Ventricular Drain Market

The South African market is projected to reach around USD 2.8 million in 2026, representing roughly 0.82% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Rise in Product Introductions by Top Companies to Boost Market Revenue

The global external ventricular drain market holds a semi-consolidated market structure, constituting prominent players such as Integra LifeSciences Corporation, Medtronic plc, Natus Medical Incorporated, Sophysa, and Spiegelberg GmbH & Co. KG. Numerous strategic activities, including distribution collaborations and implementation of new programs, drive the significant global market share of these companies.

• For instance, in January 2022, Integra LifeSciences reported positive clinical and economic evidence for its External Ventricular Drainage systems, demonstrating their potential to enhance cerebrospinal fluid management and improve neurocritical care outcomes.

Desu Medical, KoçMedical, Silmag, and Suzhou New District Mingji Polymer Medical Equipment Co., Ltd. are other prominent players in the market. They are set to prioritize collaborations to increase their global market share in the coming years.

LIST OF KEY EXTERNAL VENTRICULAR DRAIN COMPANIES PROFILED

• Integra LifeSciences Corporation (U.S.)
• Medtronic plc (Ireland)
• Natus Medical Incorporated (U.S.)
• Sophysa (France)
• Spiegelberg GmbH & Co. KG (Germany)
• Desu Medical (Türkiye)
• KoçMedical (Türkiye)
• Silmag (Argentina)
• Suzhou New District Mingji Polymer Medical Equipment Co., Ltd. (China)
• Yushin Medical Co., Ltd. (South Korea)

KEY INDUSTRY DEVELOPMENTS

• June 2026: CereVasc raised USD 85 million in Series C financing from investors, including Johnson & Johnson Innovation and Medtronic to support its pivotal STRIDE trial and future commercialization of the eShunt System, a minimally invasive cerebrospinal fluid (CSF) diversion technology.
• May 2026: Zeta Surgical received FDA clearance for its AI-powered Zeta Navigation System, along with the Zeta Stylet and Zeta Bolt instruments, enabling real-time image-guided support for external ventricular drain placement, shunt procedures, and hydrocephalus management.
• January 2026: BrainSpace received FDA clearance for Intellidrop, an automated cerebrospinal fluid drainage and intracranial pressure monitoring system.
• June 2025: Researchers from the Institute for Basic Science (IBS) demonstrated that non-invasive mechanical stimulation of cervical lymphatic vessels significantly enhanced cerebrospinal fluid (CSF) drainage and brain waste clearance in preclinical models.
• July 2023: Anuncia Medical commercially launched the second-generation ReFlow Mini Flusher across leading U.S. neurosurgical centers for the treatment of hydrocephalus.

REPORT COVERAGE

The global external ventricular drain market analysis includes a comprehensive study of the market size & forecast by all the market segments included in the report. It includes details on the market dynamics and market trends expected to drive the market over the forecast period. It provides information on key aspects, including an overview of technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers & acquisitions, as well as key industry developments and investments by key regions. The global market research report also provides a detailed competitive landscape with information on the market share and profiles of key operating players.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation